Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Ethical Standards II

Ethical Standards II

Ethical standards are the backbone of nursing practice, guiding nurses as they interact with patients, families, and colleagues. These standards are crucial for providing safe, empathetic care centered on the patient's needs.
Nurses are entrusted with upholding various ethical principles and standards. Nurses forge solid therapeutic relationships using trust, empathy, autonomy, confidentiality, and professional competence.
Confidentiality is crucial, embodying respect for individual privacy...

Ethical Standards I

Ethical Standards I

The American Nurses Association (ANA) created and implemented the first nationally accepted Code of Ethics for Nurses with Interpretive Statements. The Code of Ethics is a living document regularly updated by the ANA and establishes an ethical standard that is non-negotiable for nurses in all roles and settings.
The Code of Ethics provisions outline the nurse's duty to the patient, the healthcare team, the profession, and society. The Code's fundamental principles include advocacy,...

Quality Assurance

Quality Assurance

Quality assurance is the overarching term used to describe the activities employed to ensure the proper performance of a system. These activities can be classified into three categories: quality control, quality assessment, and internal corrective measures. Typically, these activities work cyclically: quality control is performed before and during the analysis, while quality assessment occurs during and after the investigation. Internal corrective measures are implemented based on the findings...

Improving Translational Accuracy

Improving Translational Accuracy

Sustainable Development

Sustainable Development

As the human population continues to grow and use resources, we must be mindful of our planet’s natural limits. Sustainable development provides a pathway to maintain and improve human life now while also ensuring that future generations will have the resources that they need. The long-term success of sustainability efforts rests on understanding the interplay between human actions and ecological systems.

Self-Discrepancy Theory

Self-Discrepancy Theory

One influential perspective on what motivates people's behavior is detailed in Tory Higgin's self-discrepancy theory (Higgins, 1987). He proposed that people hold disagreeing internal representations of themselves that lead to different emotional states.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

More Social needed by the Sciences.

EMBO reports·2025

Same author

The launch of EMBO reports 25 years ago.

EMBO reports·2025

Same author

Too much charity?

EMBO reports·2025

Same author

Culture and its impact on research.

EMBO reports·2025

Same author

Scientific truth: an endangered species.

EMBO reports·2024

Same author

Genetic information and insurance.

EMBO reports·2024

Search research articles

Related Experiment Video

Updated: Aug 9, 2025

Regulatory T cells: Therapeutic Potential for Treating Transplant Rejection and Type I Diabetes

Regulatory T cells: Therapeutic Potential for Treating Transplant Rejection and Type I Diabetes

Published on: August 20, 2007

We can do better.

¹QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia.

|February 23, 2023

Summary

This summary is machine-generated.

Rapid vaccine development has curbed the pandemic. However, developing therapies for other major diseases remains a significant challenge, requiring further research and innovation.

More Related Videos

A Novel Method for Involving Women of Color at High Risk for Preterm Birth in Research Priority Setting

A Novel Method for Involving Women of Color at High Risk for Preterm Birth in Research Priority Setting

Published on: January 12, 2018

In Vitro Selection of Engineered Transcriptional Repressors for Targeted Epigenetic Silencing

In Vitro Selection of Engineered Transcriptional Repressors for Targeted Epigenetic Silencing

Published on: May 5, 2023

Related Experiment Videos

Last Updated: Aug 9, 2025

Regulatory T cells: Therapeutic Potential for Treating Transplant Rejection and Type I Diabetes

Regulatory T cells: Therapeutic Potential for Treating Transplant Rejection and Type I Diabetes

Published on: August 20, 2007

A Novel Method for Involving Women of Color at High Risk for Preterm Birth in Research Priority Setting

A Novel Method for Involving Women of Color at High Risk for Preterm Birth in Research Priority Setting

Published on: January 12, 2018

In Vitro Selection of Engineered Transcriptional Repressors for Targeted Epigenetic Silencing

In Vitro Selection of Engineered Transcriptional Repressors for Targeted Epigenetic Silencing

Published on: May 5, 2023

Area of Science:

Medical research
Pharmaceutical development
Disease intervention

Background:

The COVID-19 pandemic highlighted the potential for accelerated vaccine development.
Despite advances, the development timeline for therapies targeting other diseases remains lengthy.
Existing therapeutic development pipelines face numerous hurdles.

Purpose of the Study:

To investigate the reasons behind the prolonged development of therapies for major diseases.
To compare the development processes of vaccines and therapeutics.
To identify potential strategies for expediting therapeutic development.

Main Methods:

Comparative analysis of drug and vaccine development lifecycles.
Review of regulatory pathways and funding mechanisms.
Examination of scientific and technological bottlenecks.

Main Results:

Vaccine development often benefits from established platforms and urgent public health mandates.
Therapeutic development involves complex preclinical and clinical trials with higher failure rates.
Regulatory and funding landscapes present different challenges for vaccines versus therapeutics.

Conclusions:

The distinct nature of vaccine and therapy development necessitates tailored approaches.
Streamlining regulatory processes and enhancing funding for therapeutic research are crucial.
Continued innovation in scientific methodologies is key to accelerating therapy creation.